LaSalle St. Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.21M Sell
1,315
-132
-9% -$134K 0.17% 100
2025
Q4
$1.55M Buy
1,447
+160
+12% +$153K 0.25% 66
2025
Q3
$982K Buy
1,287
+214
+20% +$159K 0.18% 91
2025
Q2
$836K Buy
1,073
+3
+0.3% +$2.33K 0.23% 93
2025
Q1
$883K Buy
1,070
+301
+39% +$250K 0.21% 88
2024
Q4
$593K Sell
769
-114
-13% -$94.4K 0.18% 111
2024
Q3
$782K Buy
883
+447
+103% +$402K 0.31% 60
2024
Q2
$395K Sell
436
-155
-26% -$124K 0.2% 94
2024
Q1
$391K Buy
591
+240
+68% +$171K 0.22% 75
2023
Q4
$2.05M Sell
351
-862
-71% -$503K 0.14% 117
2023
Q3
$651K Buy
1,213
+228
+23% +$117K 0.32% 43
2023
Q2
$461K Sell
985
-227
-19% -$95.2K 0.2% 62
2023
Q1
$416K Buy
1,212
+192
+19% +$64.8K 0.18% 70
2022
Q4
$373K Buy
+1,020
New +$362K 0.18% 67

Other funds holding LLY

LaSalle St. Investment Advisors's LLY Position: Q1 2026 in Review

LaSalle St. Investment Advisors reduced its Eli Lilly (LLY) stake by 9.1% in Q1 2026, selling an estimated $134K and leaving 1,315 shares worth $1.21M. The position accounts for 0.17% of the portfolio, ranked #100.

LaSalle St. Investment Advisors first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.05M in Q4 2023. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • LaSalle St. Investment Advisors held 1,315 shares of Eli Lilly worth $1.21M as of Q1 2026.
  • LaSalle St. Investment Advisors sold 132 Eli Lilly shares in Q1 2026, an estimated $134K.
  • Eli Lilly made up 0.17% of LaSalle St. Investment Advisors's portfolio in Q1 2026, its #100 holding.
  • LaSalle St. Investment Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • LaSalle St. Investment Advisors's Eli Lilly position peaked at $2.05M in Q4 2023.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on LaSalle St. Investment Advisors's 13F filing for Q1 2026, filed 8 May 2026.